Camden Capital, LLC Gilead Sciences, Inc. Transaction History

Camden Capital, LLC

$1.25 Billion
Q2 2024

A detailed history of Camden Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 5,738 shares of GILD stock, worth $486,238. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,738

Previous 3,298 73.98%

Holding current value

$486,238

Previous $241,000 63.07%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $154,086 - $177,827	2,440 Added 73.98%	5,738 $393,000
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $307,436 - $374,910	-4,295 Reduced 56.57%	3,298 $241,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $324,659 - $368,171	4,431 Added 140.13%	7,593 $615,000
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $16,932 - $18,473	-229 Reduced 6.75%	3,162 $236,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $6,156 - $7,022	-81 Reduced 2.33%	3,391 $261,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $41,747 - $47,563	-540 Reduced 13.46%	3,472 $288,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $427,639 - $613,943	-6,862 Reduced 63.1%	4,012 $344,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $446,371 - $509,870	7,497 Added 222.0%	10,874 $671,000
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $102,972 - $115,977	-1,784 Reduced 34.57%	3,377 $209,000
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $75,759 - $94,934	1,308 Added 33.95%	5,161 $307,000
Q4 2021 Feb 28, 2022	SELL	$64.88 - $73.64 $101,018 - $114,657	-1,557 Reduced 28.78%	3,853 $280,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $14,014 - $15,906	-216 Reduced 3.84%	5,410 $393,000
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $123,128 - $132,841	1,819 Added 47.78%	5,626 $393,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $45,634 - $49,862	-719 Reduced 15.89%	3,807 $262,000
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $16,800 - $19,168	280 Added 6.59%	4,526 $293,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $14,049 - $16,008	-248 Reduced 5.52%	4,246 $247,000
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $116,996 - $147,102	-1,884 Reduced 29.54%	4,494 $284,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $64,744 - $75,180	-895 Reduced 12.31%	6,378 $491,000
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $26,743 - $34,253	-427 Reduced 5.55%	7,273 $552,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $474,474 - $521,906	7,700 New	7,700 $500,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Gilead Sciences, Inc. Transaction History